| Author (Corporate) | European Commission: Press and Communication Service |
|---|---|
| Series Title | Press Release |
| Series Details | IP/06/102 (1.2.06) |
| Publication Date | 01/02/2006 |
| Content Type | News |
|
Acting under the EU Merger Regulation, the European Commission on 1 February 2006 authorised the planned acquisition of Sanutri AG ('Sanutri'), a subsidiary of the Swiss group Novartis AG, by ABN Amro Capital France ('ABN Amro') and the fund L Capital 2 FCPR, represented for the purpose by its managing company L Capital Management ('L Capital'). The Commission came to the conclusion that the operation would not be a significant obstacle to effective competition in the European Economic Area or any substantial part of it. |
|
| Source Link | Link to Main Source http://europa.eu/rapid/pressReleasesAction.do?reference=IP/06/102&format=HTML&aged=0&language=EN&guiLanguage=en |
| Related Links |
|
| Subject Categories | Internal Markets |
| Countries / Regions | France, Switzerland |
